COMMUNIQUÉS West-GlobeNewswire

-
Idera Pharmaceuticals Reports Results from Phase 2 Trial of IMO-8400 in Dermatomyositis
12/06/2018 -
Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs
12/06/2018 -
Restoration Robotics Launches New Continuing Education Master Class Series for the ARTAS® Robotic Hair Restoration System
12/06/2018 -
Phase 3 data in the online Journal of the American Academy of Dermatology show Aclaris' ESKATA™ is safe and effective in treating persons with raised seborrheic keratoses
12/06/2018 -
CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations
12/06/2018 -
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
12/06/2018 -
Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus
12/06/2018 -
ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to Develop QR-313 for the Treatment of Dystrophic Epidermolysis Bullosa
12/06/2018 -
Asterias Biotherapeutics Announces First Patient Dosed in First-in-Human Clinical Study of Immunotherapy AST-VAC2 in Non-Small Cell Lung Cancer
12/06/2018 -
Radient Technologies Inc. Files FDA Submission for Reducing Nicotine in Tobacco
12/06/2018 -
Pluristem Reports Positive Top-Line Results from Its Multinational Phase II Intermittent Claudication Study
12/06/2018 -
Transactions in relation to share buyback program
12/06/2018 -
Amarin and Mochida Announce Collaboration on Future Development of EPA-based Drug Products and Indications
12/06/2018 -
First Medical Patent Issued for the Oculenz™ Augmented Reality Glasses
12/06/2018 -
William Demant Holding A/S: Investor news - agenda and presentations for Capital Markets Day 2018
12/06/2018 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2018 -
Sentia Medical Sciences Inc. Appoints Dr. Yvette Taché as Chair of the Scientific Advisory Board and Announces Award of a Phase 1 Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)
12/06/2018 -
Solon Eiendom ASA : Primary insider notification
12/06/2018 -
Shire plc : Rule 2.9 Announcement
12/06/2018
Pages